Company Update

TRANSGENE BIOTEK LIMITED has published its financial results for the quarter ended June 30, 2026. The company reported total income from operations of 6.00 and a net loss after tax of -38.90. Basic and diluted earnings per share stood at Rs. -0.05. These results, which consolidate subsidiary figures, were reviewed by the Audit Committee and subsequently approved by the Board of Directors.

The full financial report is available on the company and stock exchange websites.